Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase
Tuberculosis (TB), the deadly disease caused by Mycobacterium tuberculosis (Mtb), kills more people worldwide than any other bacterial infectious disease. There has been a recent resurgence of TB drug discovery activities, resulting in the identification of a number of novel enzyme inhibitors. Many...
Saved in:
Main Authors: | Krah, Alexander, Grüber, Gerhard, Bond, Peter. J. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/163131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline
by: Sarathy, J.P., et al.
Published: (2021) -
MECHANISM OF ACTION OF THE ANTI-TUBERCULOSIS DRUG CANDIDATE TBAJ-876
by: JICKKY PALMAE SARATHY
Published: (2020) -
TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug’s uncoupler activity
by: Sarathy, Jickky Palmae, et al.
Published: (2020) -
Variations of the Mycobacterium abscessus F-ATP synthase subunit a-c interface alter binding and potency of the anti-TB drug bedaquiline
by: Krah, Alexander, et al.
Published: (2023) -
Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
by: Kundu, Subhashri, et al.
Published: (2017)